These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-001888-21 A cross-over comparative study of inhaled mannitol, alone and in combination with daily rhDNase, in children with cystic fibrosis not-yet-due
Ongoing 2005-005452-41 A phase III Multicenter, randomised, parallel, placebo-controlled, double-blind study to investigate the safety and efficacy of treatment with Bronchitol (dry powder mannitol) in the symptomatic treat... not-yet-due
Not reported Terminated 2006-004078-28 Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis – A Safety and Efficacy Study 2007-03-05 due-trials
Not reported 2007-001412-23 Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis – A Safety and Efficacy Study 2010-03-26 due-trials
Not reported Terminated 2008-002644-42 A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol over 12 months in the treatment of bronchiectasis 2008-12-19 due-trials
Listed as ongoing, but also has a completion date 2008-002740-42 Long Term Administration of Inahled Mannitol in Cystic Fibrosis - A Safety and Efficacy Study 2010-10-25 bad-data
Exempt 2008-008228-34 Determination of the pharmacokinetics of inhaled mannitol after single and multiple dosing in cystic fibrosis patients 2009-12-08 not-yet-due
Listed as ongoing, but also has a completion date 2008-008731-28 A phase III multicenter, randomized, parallel, controlled, double blind study to investigate the safety and efficacy of inhaled mannitol over 12 months in the treatment of bronchiectasis. 2013-02-28 bad-data
Not reported Terminated 2011-000126-30 A phase II, multi-centre, single blind study to evaluate the safety, tolerability and explore the efficacy of 8.0 mg ASM8 inhaled daily for 14 days in adult subjects with moderate to severe asthma 2011-12-08 due-trials
Listed as ongoing, but also has a completion date 2012-002699-14 A randomised, multicentre, double-blind, placebo-controlled, crossover trial determining the efficacy of dry powder mannitol in improving lung function in subjects with Cystic Fibrosis aged six to sev... 2015-10-02 bad-data
Listed as ongoing, but also has a completion date 2013-005357-79 Long Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects 2017-02-21 bad-data